RPG Life Sciences Limited (BOM:532983)
India · Delayed Price · Currency is INR 2,345.55
-66.85 (-2.77%)
At close: Oct 23, 2025
RPG Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 2,154 | 1,832 | 876.6 | 676.4 | 514.8 | 400 | Upgrade |
Depreciation & Amortization | 209.1 | 211.5 | 164.5 | 146.9 | 148.5 | 157.3 | Upgrade |
Other Amortization | 2.8 | 2.8 | 6.2 | 8.1 | 8.1 | 7.4 | Upgrade |
Loss (Gain) From Sale of Assets | -11.5 | -12 | -0.1 | 7.8 | - | 0.1 | Upgrade |
Loss (Gain) From Sale of Investments | -82.2 | -69.6 | -57.7 | -14.4 | -8.9 | - | Upgrade |
Provision & Write-off of Bad Debts | -16.4 | -16.2 | 27 | 5 | 0.9 | 0.8 | Upgrade |
Other Operating Activities | -1,058 | -909.8 | -2 | -32.1 | 15.2 | 52.4 | Upgrade |
Change in Accounts Receivable | -301.9 | -357.5 | -142.5 | -54 | 248.1 | 62.2 | Upgrade |
Change in Inventory | -96.4 | 61.9 | -59.5 | -120.6 | -246.6 | -117.2 | Upgrade |
Change in Accounts Payable | 296.5 | 95.4 | 63.3 | 192.6 | -19.1 | 31.2 | Upgrade |
Change in Other Net Operating Assets | -668 | -60.3 | 67.8 | 92.5 | -13.5 | -11.5 | Upgrade |
Operating Cash Flow | 428 | 778.6 | 943.6 | 908.2 | 647.5 | 582.7 | Upgrade |
Operating Cash Flow Growth | -59.79% | -17.49% | 3.90% | 40.26% | 11.12% | 16.14% | Upgrade |
Capital Expenditures | -438 | -360.3 | -692.3 | -327.3 | -239.5 | -85.1 | Upgrade |
Sale of Property, Plant & Equipment | 1,094 | 1,095 | 1.5 | 0.8 | - | 0.5 | Upgrade |
Investment in Securities | 84 | -287.9 | -269.6 | -569.9 | -119.7 | - | Upgrade |
Other Investing Activities | -731.4 | -864.5 | 168.9 | -161.7 | 12.6 | 5 | Upgrade |
Investing Cash Flow | 8.6 | -418 | -791.5 | -1,058 | -346.6 | -79.6 | Upgrade |
Short-Term Debt Repaid | - | - | - | -2.7 | -3.1 | -46 | Upgrade |
Long-Term Debt Repaid | - | - | -0.1 | -6.6 | -7.7 | -51 | Upgrade |
Total Debt Repaid | - | - | -0.1 | -9.3 | -10.8 | -97 | Upgrade |
Net Debt Issued (Repaid) | - | - | -0.1 | -9.3 | -10.8 | -97 | Upgrade |
Common Dividends Paid | -396.9 | -264.6 | -198.5 | -158.8 | -119.1 | - | Upgrade |
Other Financing Activities | -5.5 | -6.2 | -4.5 | -3.1 | -5.2 | -7.9 | Upgrade |
Financing Cash Flow | -402.4 | -270.8 | -203.1 | -171.2 | -135.1 | -104.9 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.1 | - | - | Upgrade |
Net Cash Flow | 34.2 | 89.8 | -51 | -321.2 | 165.8 | 398.2 | Upgrade |
Free Cash Flow | -10 | 418.3 | 251.3 | 580.9 | 408 | 497.6 | Upgrade |
Free Cash Flow Growth | - | 66.45% | -56.74% | 42.38% | -18.01% | 26.20% | Upgrade |
Free Cash Flow Margin | -0.15% | 6.40% | 4.32% | 11.33% | 9.27% | 12.79% | Upgrade |
Free Cash Flow Per Share | -0.60 | 25.29 | 15.19 | 35.12 | 24.67 | 30.09 | Upgrade |
Cash Interest Paid | 5.5 | 6.2 | 4.5 | 3.1 | 5.2 | 7.9 | Upgrade |
Cash Income Tax Paid | 539.6 | 527.5 | 293.1 | 252.3 | 188.5 | 83.3 | Upgrade |
Levered Free Cash Flow | -146.2 | 325.59 | 222.04 | 487.99 | 350.38 | 367.74 | Upgrade |
Unlevered Free Cash Flow | -142.76 | 329.46 | 224.85 | 489.93 | 353.63 | 372.68 | Upgrade |
Change in Working Capital | -769.8 | -260.5 | -70.9 | 110.5 | -31.1 | -35.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.